{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:59:51Z","timestamp":1793833191707,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41591-021-01309-6","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T12:02:37Z","timestamp":1619697757000},"page":"871-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":757,"title":["Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"27","author":[{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-9940","authenticated-orcid":false,"given":"Jacob W.","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0203-3909","authenticated-orcid":false,"given":"Neil P.","family":"Oxtoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-0112","authenticated-orcid":false,"given":"Ruben","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof T.","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-8100","authenticated-orcid":false,"given":"Renaud","family":"La Joie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon M.","family":"Aksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-9022","authenticated-orcid":false,"given":"Michel J.","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9345-0347","authenticated-orcid":false,"given":"Yasser","family":"Iturria-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8419-7589","authenticated-orcid":false,"given":"Michael J.","family":"Pontecorvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6871-0063","authenticated-orcid":false,"given":"Michael D.","family":"Devous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-4265","authenticated-orcid":false,"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2439-350X","authenticated-orcid":false,"given":"Daniel C.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2231-672X","authenticated-orcid":false,"given":"Chul Hyoung","family":"Lyoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3841-6098","authenticated-orcid":false,"given":"Alan C.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-7286","authenticated-orcid":false,"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"1309_CR1","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","volume":"368","author":"MD Hurd","year":"2013","unstructured":"Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J. & Langa, K. M. Monetary costs of dementia in the United States. N. Engl. J. Med. 368, 1326\u20131334 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1309_CR2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff, I. et al. Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium. Brain Pathol. 18, 484\u2013496 (2008).","journal-title":"Brain Pathol."},{"key":"1309_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman, B. T. et al. National Institute on Aging\u2014Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 8, 1\u201313 (2012).","journal-title":"Alzheimers Dement."},{"key":"1309_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"1309_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207\u2013216 (2013).","journal-title":"Lancet Neurol."},{"key":"1309_CR6","doi-asserted-by":"crossref","first-page":"eaau5732","DOI":"10.1126\/scitranslmed.aau5732","volume":"12","author":"R La Joie","year":"2020","unstructured":"La Joie, R. et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci. Transl. Med. 12, eaau5732 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1309_CR7","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin, A. et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain 140, 3286\u20133300 (2017).","journal-title":"Brain"},{"key":"1309_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"1309_CR9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol."},{"key":"1309_CR10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll, M. et al. PET imaging of tau deposition in the aging human brain. Neuron 89, 971\u2013982 (2016).","journal-title":"Neuron"},{"key":"1309_CR11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","volume":"139","author":"A Schwarz","year":"2016","unstructured":"Schwarz, A. Regional profiles of the candidate tau PET ligand 18 F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139, 1539\u20131550 (2016).","journal-title":"Brain"},{"key":"1309_CR12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray, M. E. et al. Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 10, 785\u2013796 (2011).","journal-title":"Lancet Neurol."},{"key":"1309_CR13","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","volume":"11","author":"JL Whitwell","year":"2012","unstructured":"Whitwell, J. L. et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer\u2019s disease: a case-control study. Lancet Neurol. 11, 868\u2013877 (2012).","journal-title":"Lancet Neurol."},{"key":"1309_CR14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","volume":"94","author":"D Ferreira","year":"2020","unstructured":"Ferreira, D., Nordberg, A. & Westman, E. Biological subtypes of Alzheimer\u2019s disease: a systematic review and meta-analysis. Neurology 94, 436\u2013448 (2020).","journal-title":"Neurology"},{"key":"1309_CR15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele, R. et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain 139, 1551\u20131567 (2016).","journal-title":"Brain"},{"key":"1309_CR16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","volume":"13","author":"SJ Crutch","year":"2017","unstructured":"Crutch, S. J. et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 13, 870\u2013884 (2017).","journal-title":"Alzheimers Dement."},{"key":"1309_CR17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006\u20131014 (2011).","journal-title":"Neurology"},{"key":"1309_CR18","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","volume":"138","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele, R. et al. The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: clinical, neuroimaging and pathological features. Brain 138, 2732\u20132749 (2015).","journal-title":"Brain"},{"key":"1309_CR19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00401-017-1691-0","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond, E. et al. Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer\u2019s disease. Acta Neuropathol. 133, 933\u2013954 (2017).","journal-title":"Acta Neuropathol."},{"key":"1309_CR20","doi-asserted-by":"publisher","unstructured":"Crist, A. M. et al. Leveraging selective hippocampal vulnerability among Alzheimer\u2019s disease subtypes reveals a novel tau binding partner SERPINA5. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.12.18.423469 (2020).","DOI":"10.1101\/2020.12.18.423469"},{"key":"1309_CR21","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.0000000000004670","volume":"89","author":"SL Risacher","year":"2017","unstructured":"Risacher, S. L. et al. Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline. Neurology 89, 2176\u20132186 (2017).","journal-title":"Neurology"},{"key":"1309_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jalz.2019.08.201","volume":"16","author":"R Ossenkoppele","year":"2020","unstructured":"Ossenkoppele, R. et al. Distinct tau PET patterns in atrophy\u2010defined subtypes of Alzheimer\u2019s disease. Alzheimers Dement. 16, 335\u2013344 (2020).","journal-title":"Alzheimers Dement."},{"key":"1309_CR23","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young, A. L. et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat. Commun. 9, 4273 (2018).","journal-title":"Nat. Commun."},{"key":"1309_CR24","first-page":"735","volume":"140","author":"A Dong","year":"2017","unstructured":"Dong, A. et al. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer\u2019s disease: links to cognition, progression and biomarkers. Brain 140, 735\u2013747 (2017).","journal-title":"Brain"},{"key":"1309_CR25","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1212\/WNL.0000000000001003","volume":"83","author":"Y Noh","year":"2014","unstructured":"Noh, Y. et al. Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs. Neurology 83, 1936\u20131944 (2014).","journal-title":"Neurology"},{"key":"1309_CR26","doi-asserted-by":"crossref","first-page":"giz055","DOI":"10.1093\/gigascience\/giz055","volume":"8","author":"A Tam","year":"2019","unstructured":"Tam, A. et al. A highly predictive signature of cognition and brain atrophy for progression to Alzheimer\u2019s dementia. Gigascience 8, giz055 (2019).","journal-title":"Gigascience"},{"key":"1309_CR27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hbm.24401","volume":"40","author":"JW Vogel","year":"2019","unstructured":"Vogel, J. W. et al. Data-driven approaches for tau-PET imaging biomarkers in Alzheimer\u2019s disease. Hum. Brain Mapp. 40, 638\u2013651 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"1309_CR28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","volume":"77","author":"A Leuzy","year":"2020","unstructured":"Leuzy, A. et al. Diagnostic performance of RO948 F 18 tau positron emission tomography in the differentiation of Alzheimer disease from other neurodegenerative disorders. JAMA Neurol. 77, 955\u2013965 (2020).","journal-title":"JAMA Neurol."},{"key":"1309_CR29","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel, J. W. et al. Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease. Nat. Commun. 11, 2612 (2020).","journal-title":"Nat. Commun."},{"key":"1309_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0891988706297086","volume":"20","author":"GA Marshall","year":"2007","unstructured":"Marshall, G. A., Fairbanks, L. A., Tekin, S., Vinters, H. V. & Cummings, J. L. Early-onset Alzheimer\u2019s disease is associated with greater pathologic burden. J. Geriatr. Psychiatry Neurol. 20, 29\u201333 (2007).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"1309_CR31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jalz.2018.12.016","volume":"15","author":"JL Whitwell","year":"2019","unstructured":"Whitwell, J. L. et al. The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer\u2019s disease. Alzheimers Dement. 15, 675\u2013685 (2019).","journal-title":"Alzheimers Dement."},{"key":"1309_CR32","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awz090","volume":"142","author":"MJ Pontecorvo","year":"2019","unstructured":"Pontecorvo, M. J. et al. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer\u2019s disease dementia. Brain 142, 1723\u20131735 (2019).","journal-title":"Brain"},{"key":"1309_CR33","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1093\/brain\/awaa248","volume":"143","author":"CR Jack","year":"2020","unstructured":"Jack, C. R. et al. Predicting future rates of tau accumulation on PET. Brain 143, 3136\u20133150 (2020).","journal-title":"Brain"},{"key":"1309_CR34","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1212\/WNL.0000000000011270","volume":"96","author":"R La Joie","year":"2021","unstructured":"La Joie, R. et al. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology 96, e650\u2013e661 (2021).","journal-title":"Neurology"},{"key":"1309_CR35","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","volume":"26","author":"S Dujardin","year":"2020","unstructured":"Dujardin, S. et al. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease. Nat. Med. 26, 1256\u20131263 (2020).","journal-title":"Nat. Med."},{"key":"1309_CR36","doi-asserted-by":"crossref","first-page":"eaat8462","DOI":"10.1126\/scitranslmed.aat8462","volume":"11","author":"A Aoyagi","year":"2019","unstructured":"Aoyagi, A. et al. A\u03b2 and tau prion-like activities decline with longevity in the Alzheimer\u2019s disease human brain. Sci. Transl. Med. 11, eaat8462 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1309_CR37","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3233\/JAD-2010-1337","volume":"19","author":"ELGE Koedam","year":"2010","unstructured":"Koedam, E. L. G. E. et al. Early-versus late-onset Alzheimer\u2019s disease: more than age alone. J. Alzheimers Dis. 19, 1401\u20131408 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"1309_CR38","doi-asserted-by":"crossref","first-page":"116043","DOI":"10.1016\/j.neuroimage.2019.116043","volume":"201","author":"N Sun","year":"2019","unstructured":"Sun, N., Mormino, E. C., Chen, J., Sabuncu, M. R. & Yeo, B. T. T. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer\u2019s disease. Neuroimage 201, 116043 (2019).","journal-title":"Neuroimage"},{"key":"1309_CR39","doi-asserted-by":"crossref","first-page":"eabd1327","DOI":"10.1126\/sciadv.abd1327","volume":"6","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier, N. et al. Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer\u2019s disease. Sci. Adv. 6, eabd1327 (2020).","journal-title":"Sci. Adv."},{"key":"1309_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000106996","volume":"3","author":"EB Mukaetova-Ladinska","year":"1992","unstructured":"Mukaetova-Ladinska, E. B. et al. Regional distribution of paired helical filaments and normal tau proteins in aging and in Alzheimer\u2019s disease with and without occipital lobe involvement. Dement. Geriatr. Cogn. Disord. 3, 61\u201369 (1992).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"1309_CR41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00005072-200606000-00010","volume":"65","author":"AC McKee","year":"2006","unstructured":"McKee, A. C. et al. Visual association pathology in preclinical Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 621\u2013630 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1309_CR42","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/NEN.0b013e3181a6ee45","volume":"68","author":"M Pikkarainen","year":"2009","unstructured":"Pikkarainen, M., Kauppinen, T. & Alafuzoff, I. Hyperphosphorylated tau in the occipital cortex in aged nondemented subjects. J. Neuropathol. Exp. Neurol. 68, 653\u2013660 (2009).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1309_CR43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","volume":"77","author":"FS Hanna Al-Shaikh","year":"2019","unstructured":"Hanna Al-Shaikh, F. S. et al. Selective vulnerability of the nucleus basalis of Meynert among neuropathologic subtypes of Alzheimer disease. JAMA Neurol. 77, 225\u2013233 (2019).","journal-title":"JAMA Neurol."},{"key":"1309_CR44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-020-00620-7","volume":"12","author":"A Machado","year":"2020","unstructured":"Machado, A. et al. The cholinergic system in subtypes of Alzheimer\u2019s disease: an in vivo longitudinal MRI study. Alzheimers Res. Ther. 12, 51 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"1309_CR45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archneurol.2007.34","volume":"65","author":"E Rogalski","year":"2008","unstructured":"Rogalski, E., Johnson, N., Weintraub, S. & Mesulam, M. Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives. Arch. Neurol. 65, 244\u2013248 (2008).","journal-title":"Arch. Neurol."},{"key":"1309_CR46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele, R. et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. JAMA 320, 1151\u20131162 (2018).","journal-title":"JAMA"},{"key":"1309_CR47","doi-asserted-by":"crossref","first-page":"fcz027","DOI":"10.1093\/braincomms\/fcz027","volume":"1","author":"ZA Miller","year":"2019","unstructured":"Miller, Z. A. Cortical developmental abnormalities in logopenic variant primary progressive aphasia with dyslexia. Brain Commun. 1, fcz027 (2019).","journal-title":"Brain Commun."},{"key":"1309_CR48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.neuron.2014.06.004","volume":"82","author":"BT Hyman","year":"2014","unstructured":"Hyman, B. T. Tau propagation, different tau phenotypes, and prion-like properties of tau. Neuron 82, 1189\u20131190 (2014).","journal-title":"Neuron"},{"key":"1309_CR49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41467-019-13787-x","volume":"11","author":"Z He","year":"2020","unstructured":"He, Z. et al. Transmission of tauopathy strains is independent of their isoform composition. Nat. Commun. 11, 7 (2020).","journal-title":"Nat. Commun."},{"key":"1309_CR50","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41593-020-00764-7","volume":"24","author":"K Leng","year":"2021","unstructured":"Leng, K. et al. Molecular characterization of selectively vulnerable neurons in Alzheimer\u2019s disease. Nat. Neurosci. 24, 276\u2013287 (2021).","journal-title":"Nat. Neurosci."},{"key":"1309_CR51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.dadm.2018.01.007","volume":"10","author":"L Lemoine","year":"2018","unstructured":"Lemoine, L., Leuzy, A., Chiotis, K., Rodriguez-Vieitez, E. & Nordberg, A. Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding. Alzheimers Dement. (Amst.) 10, 232\u2013236 (2018).","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"1309_CR52","doi-asserted-by":"publisher","unstructured":"Baker, S. L., Harrison, T. M., Maa\u00df, A., La Joie, R. & Jagust, W. Effect of off-target binding on 18 F-flortaucipir variability in healthy controls across the lifespan. J. Nucl. Med. https:\/\/doi.org\/10.2967\/jnumed.118.224113 (2019).","DOI":"10.2967\/jnumed.118.224113"},{"key":"1309_CR53","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00259-019-04496-0","volume":"47","author":"R Smith","year":"2020","unstructured":"Smith, R. et al. Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948. Eur. J. Nucl. Med. Mol. Imaging 47, 342\u2013354 (2020).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1309_CR54","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","volume":"77","author":"AS Fleisher","year":"2020","unstructured":"Fleisher, A. S. et al. Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes. JAMA Neurol. 77, 829\u2013839 (2020).","journal-title":"JAMA Neurol."},{"key":"1309_CR55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","volume":"16","author":"VJ Lowe","year":"2020","unstructured":"Lowe, V. J. et al. Tau-positron emission tomography correlates with neuropathology findings. Alzheimers Dement. 16, 561\u2013571 (2020).","journal-title":"Alzheimers Dement."},{"key":"1309_CR56","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","volume":"143","author":"DN Soleimani-Meigooni","year":"2020","unstructured":"Soleimani-Meigooni, D. N. et al. 18F-flortaucipir PET to autopsy comparisons in Alzheimer\u2019s disease and other neurodegenerative diseases. Brain 143, 3477\u20133494 (2020).","journal-title":"Brain"},{"key":"1309_CR57","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2018.3692","volume":"76","author":"R Smith","year":"2019","unstructured":"Smith, R., Wibom, M., Pawlik, D., Englund, E. & Hansson, O. Correlation of in vivo [18F]flortaucipir with postmortem Alzheimer disease Tau pathology. JAMA Neurol. 76, 310\u2013317 (2019).","journal-title":"JAMA Neurol."},{"key":"1309_CR58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neurobiolaging.2018.04.007","volume":"68","author":"H Cho","year":"2018","unstructured":"Cho, H. et al. Predicted sequence of cortical tau and amyloid-\u03b2 deposition in Alzheimer disease spectrum. Neurobiol. Aging 68, 76\u201384 (2018).","journal-title":"Neurobiol. Aging"},{"key":"1309_CR59","doi-asserted-by":"crossref","first-page":"e1003956","DOI":"10.1371\/journal.pcbi.1003956","volume":"10","author":"Y Iturria-Medina","year":"2014","unstructured":"Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J. & Evans, A. C. Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders. PLoS Comput. Biol. 10, e1003956 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"1309_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/conf.fninf.2014.08.00117","author":"C Craddock","year":"2013","unstructured":"Craddock, C. et al. Towards automated analysis of connectomes: the configurable pipeline for the analysis of connectomes (C-PAC). Front. Neuroinform. https:\/\/doi.org\/10.3389\/conf.fninf.2014.08.00117 (2013).","journal-title":"Front. Neuroinform."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-021-01309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-021-01309-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-021-01309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T20:24:39Z","timestamp":1698956679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01309-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1038\/s41591-021-01309-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740018688.793585521","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.740018688.793591632","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.740018688.793588113","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.J.P. and M.D.D. are employees of AVID Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, and are minor stockholders in Eli Lilly and Company. O.H. has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, Eli Lilly and Company, Eisai, GE Healthcare, Pfizer and Roche. In the past two years, he has received consultancy\/speaker fees from AC Immune, ALZpath, Biogen, Cerveau and Roche. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}